Engraftment of Intraperitoneally Injected Bone Marrow Cells to Newborn Mice Injected with an Angiogenesis Inhibitor.
- Author:
Su Jin CHO
1
;
Sun Young JU
;
So Youn WOO
;
Hyoung Jin KANG
;
Hyo Seop AHN
;
Kyung Ha RYU
;
Eun Ae PARK
Author Information
1. Department of Pediatrics, Ewha Womans University School of Medicine, Seoul, Korea. ujin-cho@ewha.ac.kr
- Publication Type:Original Article
- Keywords:
Alveolarization;
Bone marrow cell;
Engraftment
- MeSH:
Animals;
Bone Marrow;
Bone Marrow Cells;
Bronchopulmonary Dysplasia;
Cinnamates;
Endothelial Cells;
Epithelial Cells;
Green Fluorescent Proteins;
Humans;
Infant, Newborn;
Injections, Intraperitoneal;
Lung;
Major Histocompatibility Complex;
Mice;
Microscopy, Confocal;
Stem Cells
- From:Journal of the Korean Society of Neonatology
2008;15(1):22-31
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Bronchopulmonary dysplasia (BPD) is characterized by arrested vascular and alveolar growth in the premature lung. Considering the consequences of arrested lung growth, the idea of administering bone marrow cells to enhance the inborn repair mechanism is promising as this may reduce the morbidity and mortality of BPD. We followed enhanced green fluorescent protein (EGFP)-labeled bone marrow cells (BMC) injected intraperitoneally into non-EGFP mice in order to determine their fate after transplantation. METHODS: An angiogenesis inhibitor, SU1498, was injected subcutaneously on day 3 in non-EGFP C57BL/6 newborn mice to create a model of arrested alveolar development. On the following day, 1x10(6) BMCs isolated from major histocompatibility complex (MHC)- matched syngenic EGFP mice were injected intraperitoneally to non-EGFP BPD mice. Morphometric analysis, immunostaining, and confocal microscopy were performed to determine the fate of EGFP-positive stem cells in the injured lung. RESULTS: SU1498 injection reduced alveolar surface area and mean alveolar volume in newborn mice. BMC injection resulted in recovery of lung structure comparable to controls. EGFP-positive BMCs were identified in the lungs of the recipient mice after intraperitoneal injection. The injected EGFP cells were co-stained with endothelial and epithelial cells of the developing lung as determined by confocal microscopy. CONCLUSION: Our results illustrated that EGFP-positive BMCs engrafted and trans- differentiated into epithelial and endothelial cells after intraperitoneal injection in a mouse model of arrested alveolar development.
